Literature DB >> 34981765

Catalytically active holo Homo sapiens adenosine deaminase I adopts a closed conformation.

Minh Thu Ma1, Maria Rain Jennings2, John Blazeck2, Raquel L Lieberman1.   

Abstract

Homo sapiens adenosine deaminase 1 (HsADA1; UniProt P00813) is an immunologically relevant enzyme with roles in T-cell activation and modulation of adenosine metabolism and signaling. Patients with genetic deficiency in HsADA1 suffer from severe combined immunodeficiency, and HsADA1 is a therapeutic target in hairy cell leukemias. Historically, insights into the catalytic mechanism and the structural attributes of HsADA1 have been derived from studies of its homologs from Bos taurus (BtADA) and Mus musculus (MmADA). Here, the structure of holo HsADA1 is presented, as well as biochemical characterization that confirms its high activity and shows that it is active across a broad pH range. Structurally, holo HsADA1 adopts a closed conformation distinct from the open conformation of holo BtADA. Comparison of holo HsADA1 and MmADA reveals that MmADA also adopts a closed conformation. These findings challenge previous assumptions gleaned from BtADA regarding the conformation of HsADA1 that may be relevant to its immunological interactions, particularly its ability to bind adenosine receptors. From a broader perspective, the structural analysis of HsADA1 presents a cautionary tale for reliance on homologs to make structural inferences relevant to applications such as protein engineering or drug development.

Entities:  

Keywords:  adenosine deaminase 1; closed conformation; homologs; structural inference

Mesh:

Substances:

Year:  2022        PMID: 34981765      PMCID: PMC8725166          DOI: 10.1107/S2059798321011785

Source DB:  PubMed          Journal:  Acta Crystallogr D Struct Biol        ISSN: 2059-7983            Impact factor:   5.699


  49 in total

1.  The critical role of the loops of triosephosphate isomerase for its oligomerization, dynamics, and functionality.

Authors:  Ataur R Katebi; Robert L Jernigan
Journal:  Protein Sci       Date:  2013-12-31       Impact factor: 6.725

2.  Adenosine deaminase interacts with A1 adenosine receptors in pig brain cortical membranes.

Authors:  C Saura; F Ciruela; V Casadó; E I Canela; J Mallol; C Lluis; R Franco
Journal:  J Neurochem       Date:  1996-04       Impact factor: 5.372

3.  Structural basis for the growth factor activity of human adenosine deaminase ADA2.

Authors:  Anton V Zavialov; Xiaodi Yu; Dorothe Spillmann; Grégoire Lauvau; Andrey V Zavialov
Journal:  J Biol Chem       Date:  2010-02-09       Impact factor: 5.157

4.  Adenosine A2B receptors behave as an alternative anchoring protein for cell surface adenosine deaminase in lymphocytes and cultured cells.

Authors:  C Herrera; V Casadó; F Ciruela; P Schofield; J Mallol; C Lluis; R Franco
Journal:  Mol Pharmacol       Date:  2001-01       Impact factor: 4.436

5.  Site-directed mutagenesis of histidine 238 in mouse adenosine deaminase: substitution of histidine 238 does not impede hydroxylate formation.

Authors:  V Sideraki; D K Wilson; L C Kurz; F A Quiocho; F B Rudolph
Journal:  Biochemistry       Date:  1996-11-26       Impact factor: 3.162

6.  Mutational analysis of active site residues of human adenosine deaminase.

Authors:  D Bhaumik; J Medin; K Gathy; M S Coleman
Journal:  J Biol Chem       Date:  1993-03-15       Impact factor: 5.157

7.  Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis.

Authors:  Pui Y Lee; Grant S Schulert; Scott W Canna; Yuelong Huang; Jacob Sundel; Ying Li; Kacie J Hoyt; Rachel B Blaustein; Alexandra Wactor; Thuy Do; Olha Halyabar; Margaret H Chang; Fatma Dedeoglu; Siobhan M Case; Esra Meidan; Mindy S Lo; Robert P Sundel; Edward T Richardson; Jane W Newburger; Michael S Hershfield; Mary Beth Son; Lauren A Henderson; Peter A Nigrovic
Journal:  Ann Rheum Dis       Date:  2019-11-09       Impact factor: 19.103

8.  Molecular Evidence of Adenosine Deaminase Linking Adenosine A2A Receptor and CD26 Proteins.

Authors:  Estefanía Moreno; Júlia Canet; Eduard Gracia; Carme Lluís; Josefa Mallol; Enric I Canela; Antoni Cortés; Vicent Casadó
Journal:  Front Pharmacol       Date:  2018-02-15       Impact factor: 5.810

9.  Highly accurate protein structure prediction for the human proteome.

Authors:  John Jumper; Demis Hassabis; Kathryn Tunyasuvunakool; Jonas Adler; Zachary Wu; Tim Green; Michal Zielinski; Augustin Žídek; Alex Bridgland; Andrew Cowie; Clemens Meyer; Agata Laydon; Sameer Velankar; Gerard J Kleywegt; Alex Bateman; Richard Evans; Alexander Pritzel; Michael Figurnov; Olaf Ronneberger; Russ Bates; Simon A A Kohl; Anna Potapenko; Andrew J Ballard; Bernardino Romera-Paredes; Stanislav Nikolov; Rishub Jain; Ellen Clancy; David Reiman; Stig Petersen; Andrew W Senior; Koray Kavukcuoglu; Ewan Birney; Pushmeet Kohli
Journal:  Nature       Date:  2021-07-22       Impact factor: 69.504

10.  Highly accurate protein structure prediction with AlphaFold.

Authors:  John Jumper; Richard Evans; Alexander Pritzel; Tim Green; Michael Figurnov; Olaf Ronneberger; Kathryn Tunyasuvunakool; Russ Bates; Augustin Žídek; Anna Potapenko; Alex Bridgland; Clemens Meyer; Simon A A Kohl; Andrew J Ballard; Andrew Cowie; Bernardino Romera-Paredes; Stanislav Nikolov; Rishub Jain; Demis Hassabis; Jonas Adler; Trevor Back; Stig Petersen; David Reiman; Ellen Clancy; Michal Zielinski; Martin Steinegger; Michalina Pacholska; Tamas Berghammer; Sebastian Bodenstein; David Silver; Oriol Vinyals; Andrew W Senior; Koray Kavukcuoglu; Pushmeet Kohli
Journal:  Nature       Date:  2021-07-15       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.